Essais liés4clinical trials
VillePraguelocalisation
PaysCzechialocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05980949

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
KarXT Alzheimer Phase 3 NCT05980949 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) RECRUITING
ACP-204 Alzheimer Phase 2/3 NCT06159673 ACP-204 in Adults With Alzheimer's Disease Psychosis RECRUITING
Donanemab Alzheimer Phase 3 NCT04437511 A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) ACTIVE_NOT_RECRUITING
MEDI0618 Migraine Phase 2 NCT06602479 AURORA — A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine ACTIVE_NOT_RECRUITING